À propos de la propriété intellectuelle Formation en propriété intellectuelle Respect de la propriété intellectuelle Sensibilisation à la propriété intellectuelle La propriété intellectuelle pour… Propriété intellectuelle et… Propriété intellectuelle et… Information relative aux brevets et à la technologie Information en matière de marques Information en matière de dessins et modèles industriels Information en matière d’indications géographiques Information en matière de protection des obtentions végétales (UPOV) Lois, traités et jugements dans le domaine de la propriété intellectuelle Ressources relatives à la propriété intellectuelle Rapports sur la propriété intellectuelle Protection des brevets Protection des marques Protection des dessins et modèles industriels Protection des indications géographiques Protection des obtentions végétales (UPOV) Règlement extrajudiciaire des litiges Solutions opérationnelles à l’intention des offices de propriété intellectuelle Paiement de services de propriété intellectuelle Décisions et négociations Coopération en matière de développement Appui à l’innovation Partenariats public-privé Outils et services en matière d’intelligence artificielle L’Organisation Travailler avec nous Responsabilité Brevets Marques Dessins et modèles industriels Indications géographiques Droit d’auteur Secrets d’affaires Académie de l’OMPI Ateliers et séminaires Application des droits de propriété intellectuelle WIPO ALERT Sensibilisation Journée mondiale de la propriété intellectuelle Magazine de l’OMPI Études de cas et exemples de réussite Actualités dans le domaine de la propriété intellectuelle Prix de l’OMPI Entreprises Universités Peuples autochtones Instances judiciaires Ressources génétiques, savoirs traditionnels et expressions culturelles traditionnelles Économie Égalité des genres Santé mondiale Changement climatique Politique en matière de concurrence Objectifs de développement durable Technologies de pointe Applications mobiles Sport Tourisme PATENTSCOPE Analyse de brevets Classification internationale des brevets Programme ARDI – Recherche pour l’innovation Programme ASPI – Information spécialisée en matière de brevets Base de données mondiale sur les marques Madrid Monitor Base de données Article 6ter Express Classification de Nice Classification de Vienne Base de données mondiale sur les dessins et modèles Bulletin des dessins et modèles internationaux Base de données Hague Express Classification de Locarno Base de données Lisbon Express Base de données mondiale sur les marques relative aux indications géographiques Base de données PLUTO sur les variétés végétales Base de données GENIE Traités administrés par l’OMPI WIPO Lex – lois, traités et jugements en matière de propriété intellectuelle Normes de l’OMPI Statistiques de propriété intellectuelle WIPO Pearl (Terminologie) Publications de l’OMPI Profils nationaux Centre de connaissances de l’OMPI Série de rapports de l’OMPI consacrés aux tendances technologiques Indice mondial de l’innovation Rapport sur la propriété intellectuelle dans le monde PCT – Le système international des brevets ePCT Budapest – Le système international de dépôt des micro-organismes Madrid – Le système international des marques eMadrid Article 6ter (armoiries, drapeaux, emblèmes nationaux) La Haye – Le système international des dessins et modèles industriels eHague Lisbonne – Le système d’enregistrement international des indications géographiques eLisbon UPOV PRISMA UPOV e-PVP Administration UPOV e-PVP DUS Exchange Médiation Arbitrage Procédure d’expertise Litiges relatifs aux noms de domaine Accès centralisé aux résultats de la recherche et de l’examen (WIPO CASE) Service d’accès numérique aux documents de priorité (DAS) WIPO Pay Compte courant auprès de l’OMPI Assemblées de l’OMPI Comités permanents Calendrier des réunions WIPO Webcast Documents officiels de l’OMPI Plan d’action de l’OMPI pour le développement Assistance technique Institutions de formation en matière de propriété intellectuelle Mesures d’appui concernant la COVID-19 Stratégies nationales de propriété intellectuelle Assistance en matière d’élaboration des politiques et de formulation de la législation Pôle de coopération Centres d’appui à la technologie et à l’innovation (CATI) Transfert de technologie Programme d’aide aux inventeurs WIPO GREEN Initiative PAT-INFORMED de l’OMPI Consortium pour des livres accessibles L’OMPI pour les créateurs WIPO Translate Speech-to-Text Assistant de classification États membres Observateurs Directeur général Activités par unité administrative Bureaux extérieurs Avis de vacance d’emploi Achats Résultats et budget Rapports financiers Audit et supervision
Arabic English Spanish French Russian Chinese
Lois Traités Jugements Parcourir par ressort juridique

Nigéria

NG020

Retour

Herbal Medicines and Related Products (Labelling) Regulations 2005


DRUGS AND RELATED PRODUCTS (REGISTRATION, ETC.)

ACT 1996 (AS AMENDED)

Herbal Medicines and Related Products

(Labelling) Regulations 2005

Commencement:

In exercise of the powers conferred on the Governing Council of

the National Agency for Food and Drug Administration and Control

(NAFDAC) by Section 8 of the Drugs and Related Products

(Registration, Etc.) Act 1993, as amended, and of all the powers

enabling it in that behalf, THE GOVERNING COUNCIL OF THE

NATIONAL AGENCY FOR FOOD AND DRUG ADMINISTRATION AND

CONTROL with the approval of the Honourable Minister of Health

hereby makes the following Regulations:-

Scope. 1. These Regulations shall apply to all labeling of herbal medicines and related products used as diagnostic, therapeutic or prophylactic agents.

Prohibition. 2. No person shall manufacture, import, export, distribute, advertise or sell any herbal medicine or related product that is not labelled as required by the provisions of these Regulations.

Adequate and clear labelling information

3.(1) All information on a label shall be -

(a) clearly and prominently displayed thereon; and

(b) readily discernible to the consumer.

(2) All labelling information shall be in English language

and may include other languages.

(3) Herbal medicines and related products labeling shall

be informative and accurate and neither promotional

in tone nor false or misleading.

(4) The labeling shall be based whenever possible on data derived from human

experience.

(5) No implied claims or suggestions of herbal medicines or related products may be made, if there is in-adequate evidence of safety or a lack of substantial evidence of effectiveness.

(6) Where a claim of effectiveness or therapeutic indication labelling is made by a herbal medicine or related product, it shall carry boldly and in close proximity to the claim, a statement to the fact that such claim have not been evaluated by the Agency, unless such claims has been clinically proven and deemed satisfactory by the Agency.

Name and Address of Manufacturer, Packer or Distributor

4.(1) The label of herbal medicines and related products in package form shall specify conspicuously the name and place of business of the manufacturer, and may

include the distributor or packer.

(2) Where a herbal medicine or related product is not manufactured by a person whose name appears on the label, the name shall reveal the connection between the person and the manufacturer, such as "Manufactured for _..__.", Distributed by____..", or any other wording that expresses the facts.

No reference to International Bodies etc.

5. No reference, direct or indirect to international bodies shall be made upon any label of herbal medicine or related product, except as prescribed by the Agency.

Declaration of ingredients

6.(1) Name or index number of colour used in the preparation shall be declared on the label.

(2) A quantitative list of ingredients of the herbal medicines by their botanical names or, by their common names, shall be declared quantitatively on the label.

Trade mark

7. (1) Where a herbal medicine or related product have a trade mark displayed on the

label, the trade mark shall not give a wrong impression of the nature, quality or substance of the herbal medicine or related product.

(2) Where the trade mark registration is in conflict with any regulations or requirements of the Agency, the latter shall supersede.

Identification Number assigned by the Agency

8. The inner and outer labels of a herbal medicine or related product shall show, in a clear terms, the Agency registration number (NAFDAC REG. NO.) assigned to it as

indicated on the certificate of registration in a manner prescribed by the Agency.

Identification mark on tablets, capsules etc.

9. (1) All tablets, capsule, caplets and similar dosage forms of herbal medicines and related products shall bear identification marks traceable to the manufacturer or holder of a certificate of registration of the herbal medicine or related product unless otherwise exempted by the Agency.

(2) Exemptions request shall be made in writing to the Agency giving reasons why a

waiver is justified.

Adequate Labelling for Herbal Medicines and Related Products

10. Herbal medicines and related products shall be properly labelled with the following information on the inner and outer labels:

(1) The brand name, botanical or common name if any shall be qualified as herbal,

homeopathic, animal or mineral medicinal product and or admixture there of.

(2) The name shall not be suggestive of therapeutic claim.

(3) Each product shall have a distinct design.

(4) A quantitative list of all ingredients of the product by their botanical or common

names.

(5) The net content of the product in terms of weight, measure, or numerical count

and shall be in metric unit.

(6) The name and address of the manufacturer.

(7) Adequate directions for safe use of the product, including amount for use in

specific age groups

(8) The lot or batch number of the product.

(9) The manufacture and expiration dates.

(10) The storage conditions.

(11) Dosage, route and frequency of administration.

(12) Indication for the product.

Labelling of bulk package

10. Where a herbal medicine or related product is sold in bulk for further manufacturing, provisions of this regulation shall not apply, provided that, the label of the bulk product contains the following information:

(1) The proprietary or brand name of the herbal medicines.

(2) The botanical or common name of the herbal medicines.

(3) A statement of net contents.

(4) An identifying lot or batch number.

(5) The manufacture and expiration dates.

(6) Statement of caution e.g. "manufacturing purpose only".

Labelling Information for Practitioners

11. All herbal medicines or related products may be accompanied by an outer label and package insert with relevant information to practitioners for the safe use of the products.

Adequate Information on the insert

12.(1) Relevant information required to appear on the package insert for Practitioners shall include:

(a) Description;

(b) Clinical Pharmacology;

(c) Indications and usage;

(d) Contraindications;

(e) Warnings against misuse;

(f) Precautions;

(g) Dosage and administration;

(h) Adverse reactions;

(i) Drug abuse and dependence;

(j) Symptoms of over dosage and antidote;

(k) How supplied;

(l) Animal Pharmacology and/or Animal;

(m) Toxicology;

(n) Clinical studies;

(o) Storage conditions;

(p) References.

(2) The labeling shall contain a "Product Title" section preceding the "Description" section.

Prohibition of Labelling of Herbal Medicines or Related Products for certain treatments

13 (1) No person shall label a herbal medicine or related product as a treatment, preventive or cure for any of the diseases, disorders or abnormal states as identified in schedule 1 to the Food and Drug Act 1990 (as amended.)

2) No person shall sell, advertise, display or orally present any herbal medicine or related product to the general public whose label contains such words as "for vitality”.

Penalty

14.(1) A person who contravenes any of the provisions of these Regulations shall be guilty of an offence and liable on conviction:-

(a) in case of an individual to imprisonment for a term not exceeding two years or to a fine not exceeding N50,000. or to both such imprisonment and fine.

(b) in the case of a body corporate to a fine not exceeding N100,000.

(2) Where an offence under this regulation is Committed by a body corporate, firm, or other association of individual-

(a) every director, manager, secretary or other similar officer of the body

corporate; or

(b) every partner or officer of the firm; or

(c) every trustee of the body concerned;

or

(d) every person concerned in the management of the affairs of the

association; or

(e) every person who was purporting to act in a capacity referred to in

paragraphs (a) to (d) of this regulation is severally guilty of that offence and

liable to be proceeded against and punished for that offence in the same

manner as if he had himself committed the offence unless he proves that the act or omission constituting the offence took place without his knowledge, consent or connivance.

Forfeiture

15. In addition to the penalty specified in regulation 14 of these Regulations, a

person convicted of an offence under these Regulations shall forfeit to the Agency, the herbal medicine or related product and whatsoever is used in connection with the commission of the offence.

Herbal medicines and related products not for use in pregnancy

16. Both the inner and outer labels of all herbal medicines and related products shall carry a warning statement directing pregnant women not to use them, except there is adequate evidence of safety in pregnancy.

Warning for Children

17. The label of all herbal medicines and related Products shall carry a warning "keep this medicine out of reach of children".

Mis-leading and Misinformation

18. (1) The label of a herbal medicine or related product with antipyretic and analgesic property shall not bear the indication "for fever" but shall be labelled "for feverish conditions" or "feverish feeling".

(2) No person shall sell, advertise, display any herbal medicine or related product with a name suggestive of the symptom, disorders, diseases or abnormal states that it is supposed to treat, prevent or cure e.g. "?. Backache Tablets".

Interpretation

19. In these regulations, unless the context otherwise requires –

"Agency" means the National Agency for Food and Drug Administration and Control;

"Botanical name" means the scientific name by which plant is identified;

"Common name" means, with reference to herbal medicine or related product, the name in English language or other such language by which the product is commonly known;

"Expiration date" means any date after which a herbal medicine or related product is not recommended for use;

"Herbal Medicines and Related Products"

include:

(a) Finished medicinal products containing plant and/or their preparation presented with therapeutic or prophylactic claim and include all preparations containing a plant material in part or wholly;

(b) Animal medicinal product which shall be defined as a finished medicinal product containing only animal material and their preparations presented with therapeutic or prophylactic claim;

(c) Mineral medicinal product which shall be defined as finished medicinal product containing only in-organic minerals and/or their preparations;

(d) Preparation or admixture thereof manufactured, sold or advertised for use in the diagnosis, treatment, mitigation or prevention of any disease, disorder, abnormal physical state or the symptom thereof, in man or animal; and

(e) Preparation or admixture used for restoring, correcting or modifying organic functions in man or in animal;

"Label" includes any legend, word or mark attached to, included in, belonging to or accompanying any herbal medicine or related product;

"Package" includes anything in which any herbal medicine or related product is wholly or partly contained, placed or packed;

"Practitioners" means any person authorized by the appropriate governmental body to practice herbal medicine; and

"Sell" includes sell, offer for sale, expose for sale, have in possession for sale.

Citation 20

These regulations may be cited as the Herbal Medicines and Related Products (Labelling) Regulations 2005.

MADE at Abuja this day of 2005

DR. ANDEM NYONG ANDEM

Chairman Governing Council

National Agency for Food and Drug Administration

and Control (NAFDAC)